Lohith Gowda
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Hematology 19
- Acute Myeloid Leukemia Research 10
- Hematopoietic Stem Cell Transplantation 9
- Chronic Myeloid Leukemia Treatments 4
- Oncology 13
- CAR-T cell therapy research 8
- Co-authors
- Stuart Seropian (15 shared papers)Amer M. Zeidan (9 shared papers)Roy F. Chemaly (4 shared papers)Bronwen E. Shaw (4 shared papers)Akshay Sharma (5 shared papers)Christopher E. Dandoy (3 shared papers)Andrew St. Martin (2 shared papers)Muhammad Bilal Abid (2 shared papers)
- Journals
- Blood (9 papers)Bone Marrow Transplantation (4 papers)Transplantation and Cellular Therapy (4 papers)Transfusion (2 papers)Blood Advances (2 papers)
- Partner nations
- United StatesIndiaUnited Arab Emirates
In The Last Decade
Lohith Gowda
33 papers receiving 445 citations
Lohith Gowda's Hit Papers
Peers
Comparison fields: 5 of 59
- Hematology 158
- Infectious Diseases 150
- Oncology 154
- Genetics 46
- Immunology 53
Countries citing papers authored by Lohith Gowda
This map shows the geographic impact of Lohith Gowda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lohith Gowda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lohith Gowda more than expected).
Fields of papers citing papers by Lohith Gowda
This network shows the impact of papers produced by Lohith Gowda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lohith Gowda. The network helps show where Lohith Gowda may publish in the future.
Co-authors
The 25 scholars most cited alongside Lohith Gowda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study Hit paper breakdown → | 2021 | 205 |
| 2 | 2022 | 38 | |
| 3 | 2020 | 26 | |
| 4 | 2021 | 23 | |
| 5 | 2018 | 17 | |
| 6 | 2018 | 15 | |
| 7 | 2020 | 13 | |
| 8 | 1979 | 12 | |
| 9 | 2019 | 12 | |
| 10 | 2023 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2020 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2019 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2023 | 4 | |
| 19 | 2019 | 4 | |
| 20 | 1980 | 3 |
About Lohith Gowda
Lohith Gowda is a scholar working on Hematology, Oncology, Genetics, Public Health, Environmental and Occupational Health and Immunology, having authored 38 papers that have together received 448 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers), CAR-T cell therapy research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (158 citations), Infectious Diseases (150 citations), Oncology (154 citations), Genetics (46 citations) and Immunology (53 citations). Lohith Gowda has collaborated with scholars based in United States, India and United Arab Emirates. Frequent co-authors include Stuart Seropian, Amer M. Zeidan, Roy F. Chemaly, Bronwen E. Shaw, Akshay Sharma, Christopher E. Dandoy, Andrew St. Martin, Muhammad Bilal Abid, Gunjan L. Shah and Marcie Riches. Their work appears in journals such as Blood, Bone Marrow Transplantation, Transplantation and Cellular Therapy, Transfusion and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.